Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.73 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.73 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.73 |
| ▸ | HTR2A | P28223 | 1/20 | 0.73 |
| ▸ | HTR2C | P28335 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | HRH1 | P35367 | 1/20 | 0.73 |
| ▸ | DRD3 | P35462 | 1/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.73 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.73 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3688450 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL8984374 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5524593 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3833693 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5519471 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL8984511 | 0.98 | CHRM1 (0.70) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Valproic Acid SCHEMBL11163012 | 0.95 | CHRM1 (0.80) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL29061428 | 0.93 | CHRM1 (0.62) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL9901936 | 0.93 | CA2 (0.65) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL49001 | 0.93 | CHRM1 (0.76) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110275520-A1 | BIODEGRADABLE CHEMICAL DELIVERY SYSTEM | CORNELL UNIVERSITY | 2011-11-10 | — | — | US | claimed |
| WO-2010039865-A2 | BIODEGRADABLE CHEMICAL DELIVERY SYSTEM | CORNELL UNIVERSITY (US) | 2010-04-08 | — | — | WO | claimed |
| EP-0614741-B1 | Method of making an elongate component and injection mold assembly for making the same | MCNEIL PPC INC (US) | 1997-12-03 | — | — | EP | claimed |
| CN-114044886-B | Production method of polycaprolactone | 青岛科技大学 | 2023-08-29 | — | — | CN | disclosed |
| US-10899729-B2 | Method for producing bicyclic compound | ONO PHARMACEUTICAL CO.. LTD. (JP) | 2021-01-26 | — | — | US | disclosed |
| US-20190315705-A1 | METHOD FOR PRODUCING BICYCLIC COMPOUND | ONO PHARMACEUTICALS CO., LTD. (JP) | 2019-10-17 | — | — | US | disclosed |
| EP-3480191-A1 | METHOD FOR PRODUCING BICYCLIC COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-9861096-B2 | Biodegradable chemical delivery system | CORNELL UNIVERSITY (US) | 2018-01-09 | — | — | US | disclosed |
| US-20110275520-A1 | BIODEGRADABLE CHEMICAL DELIVERY SYSTEM | CORNELL UNIVERSITY | 2011-11-10 | — | — | US | disclosed |
| WO-2010039865-A2 | BIODEGRADABLE CHEMICAL DELIVERY SYSTEM | CORNELL UNIVERSITY (US) | 2010-04-08 | — | — | WO | disclosed |
| EP-0614741-B1 | Method of making an elongate component and injection mold assembly for making the same | MCNEIL PPC INC (US) | 1997-12-03 | — | — | EP | disclosed |
| EP-0614741-A1 | Improved injection molded product and method | McNEIL-PPC, INC. (US) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10899729-B2 | Method for producing bicyclic compound | OXER1, CYP8B1, CYP51A1 | CHRM1 3259/4885AKR1A1 235/4885CHRM3 3092/4885 |
| US-20190315705-A1 | METHOD FOR PRODUCING BICYCLIC COMPOUND | OXER1, CYP8B1, CYP51A1 | CHRM1 3259/4885AKR1A1 235/4885CHRM3 3092/4885 |
| US-20110275520-A1 | BIODEGRADABLE CHEMICAL DELIVERY SYSTEM | FAU, DDT, PFAS | CHRM1 822/4885AKR1A1 4549/4885CHRM3 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.